Research Database

23 studies found

Positive

82.6%

Negative

4.3%

Inconclusive

13.0%

Page 1 of 2

NegativeReview/Other

Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms

2023

Cannabis Adverse EffectsPainPain - Acute+9

PositiveReview/Other

TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

2022

Pain

PositiveReview/Other

Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?

2021

Pain

InconclusiveMeta-analysis -

Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

2021

Addiction

PositiveReview/Other

International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management

2021

Addiction

InconclusiveClinical Trial

Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials

2021

Anxiety

PositiveReview/Other

Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology

2020

Pain

PositiveReview/Other

A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis

2019

Pain

PositiveMeta-analysis -

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

2017

Addiction - Opioid

PositiveMeta-analysis -

Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis

2017

Pain

PositiveReview/Other

An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.

2016

Pain

PositiveMeta-analysis -

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology

2014

Epilepsy

PositiveReview/Other

Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.

2013

Pain - Neuropathy - Peripheral

PositiveReview/Other

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

2013

Inflammation

PositiveReview/Other

Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries

2013

Pain

InconclusiveDouble Blind Clinical Trial

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

2012

Pain

PositiveClinical Trial

A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain.

2008

Pain - Neuropathy - Peripheral

PositiveClinical Trial

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial

2007

Pain

PositiveClinical Trial

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

2005

Pain

PositiveAnimal Study - Veterinary Clinical Trial

[Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication]

2005

Pain

Command Palette

Research Database

Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms

TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?

Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management

Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials

Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology

A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis

An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology

Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain.

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

[Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication]